| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |